The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production
Open accessAbstract
The partial amino acid sequence of the NH2 terminus of a factor named human B-cell differentiation factor or B-cell stimulatory factor 2 (BSF-2) has been determined. Antibodies raised against the synthetic peptide corresponding to residues 1-13 of the NH2-terminal sequence specifically react with BSF-2 generated by a T-cell line and by phytohemagglutinin-stimulated normal T cells. Furthermore, the antipeptide antibodies react with a BSF-2-like factor produced by cardiac myxoma as well as uterine cervical carcinoma cells. The results show that BSF-2 functions in vivo as well and suggest that the constitutive production of BSF-2 may be involved in autoantibody production, since patients with cardiac myxoma and uterine carcinoma showed autoantibody production.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in the 1980s also showed that IL-6 is produced by cardiac myxoma cells (42) and Castleman’s germinal center cells (43)”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [42]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,311
A gas-liquid solid phase peptide and protein sequenator.
Hewick, R. M., Hunkapiller, M. W., Hood, L., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218
Structure and expression of a cloned cDNA for human interleukin-2
Taniguchi, T., Matsui, H., Fujita, T., Takaoka, C., Kashima, N., Yoshimoto, R., & Hamuro, J. (1983) · Nature · doi:10.1038/302305a0 · Cited by 1,182
Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.
Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., & Dinarello, C. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7907 · Cited by 1,042
Cloning and expression of murine interleukin-1 cDNA in Escherichia coli
Lomedico, P. T., Gubler, U., Hellmann, C. P., Dukovich, M., Giri, J. G., Pan, Y. E., Collier, K. J., Semionow, R., Chua, A. O., & Mizel, S. B. (1984) · Nature · doi:10.1038/312458a0 · Cited by 816
Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1
Ohara, J., & Paul, W. E. (1985) · Nature · doi:10.1038/315333a0 · Cited by 712
Hirano, T., Taga, T., Nakano, N., Yasukawa, K., Kashiwamura, S., Shimizu, K., Nakajima, K., Pyun, K., & Kishimoto, T. (1985) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.82.16.5490 · Cited by 691
Self-citationExpression of human immune interferon cDNA in E. coli and monkey cells
Gray, P. W., Leung, D. W., Pennica, D., Yelverton, E., Najarian, R. C., Simonsen, C. C., Derynck, R., Sherwood, P. J., Wallace, D. M., Berger, S. L., et al. (1982) · Nature · doi:10.1038/295503a0 · Cited by 691
Replacement of T-Cell Function by a T-Cell Product
Schimpl, A., & Wecker, E. (1972) · Nature New Biology · doi:10.1038/newbio237015a0 · Cited by 529
Cited by
Sorted by citations
Items 301–350 of 350
Hayashi, T., Anayama, H., Hasegawa, K., Iwata, H., & Onodera, T. (2002) · Journal of Comparative Pathology · doi:10.1053/jcpa.2001.0536 · Cited by 3
Braun, J. G., Saxon, A., Wall, R., & Morrison, S. L. (1992) · PubMed Central · Cited by 3
Umeyama, S. (1994) · Kitakantou igaku/Kitakantō Igaku · doi:10.2974/kmj1951.44.475 · Cited by 3
Cardiovascular Effects of an Immunosuppressive Agent Cyclosporin A
Sakamoto, H., & Kurabayashi, M. (2002) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200201500201 · Cited by 3
Induction of Autoimmunity by Adjuvant Hydrocarbons
Kelly, K. M., Kuroda, Y., Nacionales, D. C., Akaogi, J., Satoh, M., & Reeves, W. H. (2004) · Elsevier eBooks · doi:10.1016/b978-044451271-0.50008-9 · Cited by 3
Immunotoxicology of Chemical Carcinogens
Sullivan, K. A., & Salvaggio, J. E. (1995) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4076-1_12 · Cited by 3
A child who was feverish for 2 years
Haddad, É., Fournet, J., Brousse, N., & Blanche, S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05200-2 · Cited by 3
Autoimmune conditions induced by epithelial solid tumors
Bataille, R., & Klein, B. (1987) · Rheumatology International · doi:10.1007/bf00270521 · Cited by 3
Cytokine action on B cells in disease
Romagnani, S. (1990) · Elsevier eBooks · doi:10.1016/b978-0-12-155145-2.50012-6 · Cited by 3
Immunological Abnormality of Peripheral Blood B Cells in Patients with Autoimmune Thyroid Disease.
Zeki, K., Tanaka, Y., Fujihira, T., Watanabe, K., SUZUKI, H., Yamashita, U., & Eto, S. (1989) · Endocrinologia Japonica · doi:10.1507/endocrj1954.36.335 · Cited by 2
Okuno, K., Yoneda, N., Nishimura, R., Sano, H., Ueyama, J., Komatsu, H., Harada, T., Matsushita, M., Kuwamoto, S., Horie, Y., et al. (2019) · Yonago acta medica · doi:10.33160/yam.2019.09.004 · Cited by 2
Anti-Interleukin-6 Receptor Antibody Therapy Against Autoimmune Inflammatory Diseases
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397933-9.00027-8 · Cited by 2
PR3-ANCA associated retinal vasculitis and atrial myxoma
Fanlo, P., & Jayne, D. R. W. (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa263 · Cited by 2
Expression of IL‐6 in Normal Individuals and in Patients with Autoimmune Diseasea
Tovey, M. G., Gresser, I., Blanchard, B., & Guymarho, J. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb24029.x · Cited by 2
Granulocyte-Macrophage Growth Factors
Quesenberry, P. J. (1992) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-75865-2_12 · Cited by 2
gp130-mediated signalling as a therapeutic target
Ohtani, T., Ishihara, K., Atsumi, T., Yoshida, Y., Nishida, K., Narimatsu, M., Shirogane, T., Hibi, M., & Hirano, T. (2000) · Emerging Therapeutic Targets · doi:10.1517/14728222.4.4.459 · Cited by 2
Self-citationCytokines in the host-tumor interaction
Sehgal, P. B. (1998) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8946-9_6 · Cited by 2
Cytokines and diseases. Abnormal expression of Interleukin 6 and diseases.
HIRANO, T. (1991) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.80.1401 · Cited by 2
Self-citationTanaka, T., Hagihara, K., Shima, Y., Narazaki, M., Ogata, A., & Kumanogoh, A. (2011) · Drug Development Research · doi:10.1002/ddr.20480
A large atrial myxoma in a young woman
Arana‐Arri, E., de Vicuña, A. G., Royo, N. L., Martín, M. C., Carbonero, D. R., & Díez, J. B. (2008) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0131-5 · Cited by 1
The study of cytokines by Japanese researchers: a historical perspective.
Kumanogoh, A., & Ogata, M. (2010) · International Immunology · doi:10.1093/intimm/dxq022 · Cited by 1
Glycosylation of Immunoglobulins
Pilkington, C., Rook, G. A. W., & Isenberg, D. A. (1994) · BioDrugs · doi:10.1007/bf03258502 · Cited by 1
Damme, J. V., Opdenakker, G., Snick, J. V., Decock, B., Lenaerts, J., Put, W., & Billiau, A. (1989) · Elsevier eBooks · doi:10.1016/b978-0-08-036149-9.50023-3 · Cited by 1
Chemokine and Cytokine Modulators
Fuentes, M. E., Mirzadegan, T., & Wilhelm, R. S. (2003) · Wiley eBooks · doi:10.1002/0471266949.bmc062 · Cited by 1
Arthralgia as the initial manifestation of malignant lymphoma
Ando, T., Shinohara, K., Nomiyama, J., Toyosawa, M., & Inoue, H. (1995) · American journal of hematology/oncology · doi:10.1002/ajh.2830500221
IgG2 and IgG4 subclass deficiency and Evan's syndrome in an adult patient
Villiger, P. M., Fey, M. F., Lotz, M., & Tobler, A. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90147-t · Cited by 1
Pratt, M. A. C., & Wall, J. R. (1989) · Autoimmunity · doi:10.3109/08916938909099016 · Cited by 1
A Phase I Study of Interleukin-10 in Healthy Humans: Safety and Effects on Cytokine Production
Chernoff, A., Granowitz, E. V., Shapiro, L., Vannier, E. G., Lonnemann, G., Angel, J. B., Orencole, S. F., Kennedy, J. S., Zhang, X.-X., Wen, H.-D., et al. (1995) · Molecular biology intelligence unit · doi:10.1007/978-3-662-22038-2_17 · Cited by 1
For Debate Interleukin-6 and insulin sensitivity: friend or foe?
Carey, A. L., & Febbraio, M. A. (2004) · Cited by 1
Studies on the Production of Recombinant Human NF-Il6 in Mouse L cell
Choi, Y., Kim, B., Kishimoto, T., & Choi, C. Y. (1992) · Springer eBooks · doi:10.1007/978-94-011-2844-5_55
Antibody and cytokine studies related to chronic lymphocytic leukemia
Quinlan, N. P. (1994) · Dublin City University Open Access Institutional Repository (Dublin City University)
Interleukin 6 and its Receptor: Pathological Role in Autoimmunity and Lymphoid Malignancy
Hirano, T., Taga, T., Yamasaki, K., Matsuda, T., Tang, B., Suematsu, S., HORII, Y., HIRATA, Y., Yawata, H., Muraguchi, A., et al. (1989) · Elsevier eBooks · doi:10.1016/b978-0-08-036149-9.50022-1
Self-citationRegulation of the B cell response by cytokines
George, A. J. T. (1991) · Transfusion Science · doi:10.1016/0955-3886(91)90008-q
HIV‐induced B Cell Stimulatory Factor 2/Interleukin‐6 (BSF2/IL6) Productiona
Nakajima, K., Martı́nez-Maza, O., Hirano, T., Breen, E. C., Nishanian, P., Salazar-Gonzalez, J. F., Fahey, J. L., & Kishimoto, T. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb24052.x
Self-citationThe blockade of interleukin-6 receptor as a therapeutic strategy for chronic inflammatory diseases
Yoshio‐Hoshino, N., Watanabe, D., Adachi, Y., & Nishimoto, N. (2004) · Therapy · doi:10.1586/14750708.1.2.267
Suzuki, Y., Matsushima, K., Abiko, Y., & Maeda, T. (2003) · International Journal of Oral-Medical Sciences · doi:10.5466/ijoms.1.130
Regulation of colony-stimulating factor production by normal and leukemic human cells
Ernst, T. J., & Griffin, J. D. (1989) · Immunologic Research · doi:10.1007/bf02918145
AlHomidani, H. H. (2015) · Surrey Research Insight Open Access (The University of Surrey)
Appenteng, K. (2009) · D-Scholarship@Pitt (University of Pittsburgh)
Kikuchi, J., Hashizume, M., Kaneko, Y., Yoshimoto, K., Nishina, N., & Takeuchi, T. (2015)
Atrial Myxoma with Disseminated Osteolytic Embolic Lesions
Chandhanayingyong, C., Thompson, S. A., Remotti, F., & Lee, F. Y. (2012) · JBJS Case Connector · doi:10.2106/jbjs.cc.l.00012
Kawagoe, M., Kawakami, M., Hirose, W., Kitani, A., Tabata, H., Hirose, T., Norioka, K., Suzuki, K., Harigai, M., Hara, M., et al. (1989) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.12.379
Studies on cytokines produced by alveolar macrophages in the patients with sarcoidosis
SHIOMI, K. (1994) · Okayama Igakkai Zasshi (Journal of Okayama Medical Association) · doi:10.4044/joma1947.106.3-4_349
Groß, V., Zhang, P., Geng, Y., Villiger, P. M., & Lotz, M. (1993)
Genetic and B Cell Functional Studies of X-Linked Immunodeficiencies
Lau, Y. (1988) · Enlighten: Theses (The University of Glasgow)
Faculty Opinions recommendation of IL-6 in inflammation, immunity, and disease.
Rose‐John, S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718634371.793577025
Kishimoto, T., & Tanaka, T. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_179
Interleukin 6 as a Mediator of the Systemic Inflammatory Response
Migliori, S. J., & Cerra, F. B. (1993) · Springer eBooks · doi:10.1007/978-3-642-77420-1_3
Role of Cytokines in the Induction of Autoimmunity
Goldman, M. (1990) · Springer eBooks · doi:10.1007/978-1-4684-8443-4_11
Metadata
- Authors
- Hirano, T., Taga, T., Yasukawa, K., Nakajima, K., Nakano, N., Takatsuki, F., Shimizu, M., Murashima, A., Tsunasawa, S., & Sakiyama, F.
- Affiliations
- The University of Osaka (JP)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1987-01
- Volume
- 84
- Issue
- 1
- Pages
- 228-231
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC304176
- OpenAlex
- W1986543207
- Cited by
- 351
- References
- 29
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 6 · 2019: 5 · 2018: 2 · 2017: 5 · 2016: 1 · 2015: 6 · 2014: 8 · 2013: 2 · 2012: 2
- FWCI
- 15.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- B cell differentiation factor, B cell stimulatory factor 2, anti-peptide antibodies, NH2-terminal sequence, autoantibody production, cardiac myxoma, uterine cervical carcinoma, T cell lines, autoantibodies
- MeSH terms
- Amino Acid Sequence, Antibodies, Autoantibodies, B-Lymphocytes, Cell Line, Chromatography, Affinity, Growth Substances, Humans, Immune Sera, Lymphokines, Interleukin-4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review